ODI Pharma AB (XSAT:ODI) EV-to-EBIT : -30.62 (As of May. 27, 2024)

ODI Pharma AB EV-to-EBIT Chart

ODI Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-7.61	-11.10	-10.93	-10.96	-19.12

Competitive Comparison of ODI Pharma AB's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, ODI Pharma AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ODI Pharma AB's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ODI Pharma AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where ODI Pharma AB's EV-to-EBIT falls into.

ODI Pharma AB EV-to-EBIT Calculation

ODI Pharma AB's EV-to-EBIT for today is calculated as:

ODI Pharma AB's current Enterprise Value is kr111.43 Mil.
ODI Pharma AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-3.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ODI Pharma AB  (XSAT:ODI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

ODI Pharma AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ODI Pharma AB's Enterprise Value for the quarter that ended in Dec. 2023 was kr69.58 Mil.
ODI Pharma AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-3.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ODI Pharma AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of ODI Pharma AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

ODI Pharma AB (XSAT:ODI) Business Description